The Gates Foundation aims to reduce maternal deaths and improve women’s health, using AI-enabled tools where possible.

Foundation Medicine’s monitoring portfolio also includes FoundationOne®Tracker, a tissue-informed ctDNA test, which launched for research use in June 2021 and investigational use in January 2023.

The funds will be used to expand the company's enterprise-grade platform, aiOS, and accelerate the development of CARE, a clinical-grade foundation model.

The IFRS Foundation Monitoring Board discussed the importance of oversight activities of the Trustees, including their responsibilities towards the International Accounting Standards Board (IASB ...